Trends in the Acute Myeloid Leukemia Treatment Market 2020-2027

 Acute myeloid leukemia (AML) is a cancer of the myeloid blood cells, causing extreme and rapid growth of abnormal white blood cells of the bone marrow. The rapid buildup of abnormal white blood cells causes interference in the production of normal blood cells. AML has a propensity to increase towards age. Replacement of normal bone marrow with cancer cells causes a drop in blood constituents such as red blood cells, platelets, white blood cells etc. which causes symptoms such as fatigue, breathlessness, easy bruising and bleeding, and increased risk of infection. The market driving factors for acute myeloid leukemia (AML) are rise in risk factors such as exposures to carcinogens such as ionizing radiation, chemicals etc. Presence of other blood disorders and genetics is also involved for the higher risk of AML. Other market drivers are increasing number of cancer hospitals, greater awareness, good reimbursement scenario etc. The market constraints are poor cure rates of the present drugs, serious side effects of the drugs etc.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3223 

Considering all these factors the market for acute myeloid leukemia treatment is expected to reach $ 1.2 billion by the end of 2023, this market is projected to growing at a CAGR of Approx 5.3 % during 2017-2023.

Key players of Global Acute Myeloid Leukemia Treatment Market

Key players profiled in the report are Johnson & Johnson, Pfizer Inc., Celgene Corporation, Ambit Biosciences Corporation, Cyclacel Pharmaceuticals Inc. Novartis AG and Sanofi, Bristol Myers Squibb and others.

Segments

The global acute myeloid leukemia treatment market is segmented on the basis of disease type. Based on the disease type, the market has been segmented as myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia and megakaryocytic. Based on the treatment, the market has been segmented as chemotherapy, and hematopoietic stem cell transplantation. Chemotherapy is further sub-segmented into induction and post remission.

Intended Audience

• Global acute myeloid leukemia treatment solutions providers.
• Research and development (R&D) companies
• Market research and consulting service providers
• Academic institutes and universities

Regional Analysis

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and presence of large hospitals. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.

The report for Global Acute Myeloid Leukemia (AML) Therapeutics Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/acute-myeloid-leukemia-treatment-market-3223 

Sterilization Technology Market Analysis and Value Forecast Snapshot by End-use Industry 2020-2023

 Market Overview

The global sterilization technique market is predicted to touch a valuation of USD 8.14 billion with an astonishing CAGR of 8.20% during the assessment period (2018-2023), reports Market Research Future (MRFR).

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1312 

Market Dynamics

Sterilization technology is in high demand all over the world. Furthermore, as the prevalence of chronic disease increases, so will the demand for surgical procedures, raising the market for sterilization technology. Patient protection is a significant priority that all healthcare providers must strive for. As a result, healthcare providers should keep medical instruments and equipment sterile to prevent patient-acquired infections as a result of any diagnostic, clinical, or surgical procedures performed in the hospital. Furthermore, as sterilization technology is the most commonly used equipment in all specialty, multi-specialty, and super-specialty hospitals, rising concern about access to secure and quality healthcare is driving the demand for sterilization technology. The number of surgical procedures has increased dramatically as a result of rising personal healthcare expenditures and a well-structured healthcare system. Several surgical instruments are used in these operations, and the risk of contracting diseases during the operation is high. As a result, sterilization is necessary to protect patients' health.

Technological advances play an important role as well. Steam, ethylene oxide (EO), ionizing radiation (gamma or E-beam), low-temperature steam and formaldehyde, and dry heat (hot air) have all undergone significant improvements to become more precise and dependable. Recent additions such as ultraviolet light have given the advancing sterilization industry a major boost.

Higher costs of sterilization equipment and devices, on the other hand, could stifle market growth during the forecast period. Furthermore, the cost of sterilization equipment maintenance and replacement parts could limit market growth. Thermal sterilizers, for example, are constantly in need of steam, electricity, and water, all of which add to the cost. Furthermore, strict regulations can stifle market expansion. Before going into full-fledged production, manufacturers need component approvals, which can be time-consuming.

Segmental Analysis

The global sterilization technology market can be segmented by type, process, and end-user.

Type-wise segmentation includes ionizing radiation, filtration, thermal sterilization, ethylene oxide, and others. Because of its high penetration, the intensity of the radiation dose, and exposure duration, ethylene oxide (EO) has the largest market share. During the forecast period, the EO market is projected to hit USD 3.82 billion. However, its negative health effects may boost the demand for ionizing radiation, which is expected to rise and catch up to EO.

By process, the market is segmented into physicochemical, synergetic processes, chemical process, and physical processes. By 2023, the chemical process is projected to generate the most revenue, with a value of USD 5.67 billion.

Based on the end-user, the market comprises hospitals and clinics, the pharmaceutical industry, and medical device manufacturers. During the review period, the pharmaceutical sector is projected to bring in the most revenue.

Regional Analysis

Geographically the global sterilization market covers namely the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa.

The Americas dominated the global market in 2017, producing 40.1 percent of sales, and are projected to continue to do so over the forecast period. The market is being driven by the growing prevalence of chronic diseases and the increasing number of patients admitted to hospitals for surgical procedures. In addition, the area has a well-developed healthcare system with better facilities and cutting-edge technology, resulting in better surgical outcomes. Because of concerns about patient safety and preventing infection, there is a growing demand for sterilization technology around the world. Furthermore, as the demand for surgical procedures grows, so does the demand for sterilization technology, boosting the market's growth. Because of the numerous applications in pharmaceuticals, the increasing need for sterilization technology, and the involvement of major market players, North America is projected to be the largest market for sterilization technology.

Because of the benefits it reaps from growing healthcare expenditures, an aging population, and the involvement of a number of major market players, Europe is closely following the lead. The demand for technical innovation in sterilization technology is growing, which involves a variety of sterilization systems and processes.

APAC has developed a plethora of opportunities for business expansion. The area has a large population base, including a sizable geriatric population. At the same time, healthcare costs are increasing as a result of the introduction of emerging technology that enhance outcomes. Governments are also investing aggressively in research and growth, improving business opportunities.

Competitive Analysis

Advanced Sterilization Products Services Inc., Donaldson Company, Inc., Steris Plc, and The 3M Company are market leaders sharing among them the maximum percentage of the global market. Among others influencing the market are Atec Pharmatechnik GmbH, Sterile Technologies Inc. Feldmeier Equipment Co., Donaldson Co. Inc., and Beta Star Life Science Equipment.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/sterilization-technologies-market-1312 

Influenza Vaccines Market: Facts, Figures and Analytical Insights, 2020 to 2025

 Market Research Future (MRFR) assessed the global influenza vaccines market 2020 through the review period till 2025. As per MRFR study, the influenza vaccine market is expected to register 6.53% CAGR through the study period. By 2025, the influenza vaccine market value is likely to touch USD 7,828.3 Mn by 2025. The COVID 19 pandemic is expected to contribute significantly to the upsurge of the influenza vaccine market owing the the panic induced by the contagion SARS-CoV-2 and its mutating strains. The surge in demand for vaccination to restore and enhance public health from infectious virus can favor the global influenza vaccines market in the foreseeable future. Moreover, the growing cases of avian flue can contribute to the increasing sales influenza vaccines that can benefit the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1621 

Market Drivers and Restrains

The infection of the upper respiratory airway induced by an influenza virus is commonly called as flu, characterized by high fever, coughing, headache, sore throat, and sneezing. The increase in number of people diagnosed with different strain of influenza is creating the need for effective diagnosed to deliver best treatment regimen. Recently, influenza epidemics are also recorded across several regions. Thus, the increasing awareness about such infections have resulted in the launching of effective measures by both government and global healthcare leaders to boost community health. The increase in  funding for research and development undertaking to boost preparedness for epidemic and introduce product that can offer better influenza management can add to the market impetus.

Segment Assessment of Global Influenza Vaccination Market  

The segment assessment of the global influenza vaccines market is based on influenza Type, End User, Manufacturing Technology, and Vaccine Type.

The influenza type-based segments of the global influenza market are zoonotic and seasonal. The seasonal segment can rise at high pace owing to the rise in epidemic in certain region over a period of time in a year.

The manufacturing technology-based segments of the influenza market are egg-based, recombinant-based, and cell culture-based. The recombinant-based segment can acquire high revenue from the market owing to the introduction of several innovation by reputed biotechnology companies focusing on improve health and quality of life of people. The cell-culture based manufacturing technology can be gain traction. 

The vaccine type-based segments of the global influenza vaccines market are quadrivalent vaccines and trivalent vaccines. The trivalent vaccines segment is expected to thrive due to its convenience.

The end user-based segments of the global influenza vaccines market are hospitals and clinics, academic institutions, and research organizations among others. The academic institution segment can benefit the global influenza vaccines market, following the hospitals and clinics segment.

Regional Analysis of Global Influenza Vaccination Market  

North America is expected to head the global influenza vaccination market in terms of market size. The high prevalence of influenza and hike in per capita healthcare expenditure can drive North America influenza vaccination market in the near future. The existence of well-developed economies, such as Canada and the U.S. can garner decent revenue for the influenza vaccination market in the near future. The expansion of the ageing population and their high susceptibility to infectious ailments are causes contributing to the increasing demand for influenza vaccine that can prompt the growth of the influenza vaccination market.

In Europe, the influenza vaccination market can garner decent profit owing to the easy availability of funds for research to develop effective solutions to the increasing number of flu epidemics. Companies, such as Novartis AG and F. Hoffmann-La Roche Ltd, are influence EU influenza vaccination market.

In Asia Pacific, the influenza vaccination market can acquire high revenue for the global market in the assessment tenure. India and Japan are introducing favourable government healthcare policies for the expanding geriatric population that can promote the market surge. 

In The Middle East and Africa region, the influenza vaccination market is expected to experience a sluggish growth. This is due to the several socioeconomic constrains. Latin America influenza vaccination market can witness passive surge due to the gradual development of the medical and technical setup in the region.

Key Influenza Vaccination Market Players 

Abbott (U.S.), AstraZeneca (Europe), Novartis AG (Europe),  BioCryst Pharmaceuticals, Inc. (U.S.), GlaxoSmithKline plc. (Europe). DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific), Hualan Biological Engineering Inc (Asia Pacific),  F. Hoffmann-La Roche Ltd (Europe), Mitsubishi Tanabe Pharma Corporation (Asia Pacific), Paxvax Corporation (U.S.), and Sanofi (Europe) are some top-notch companies that are enlisted by MRFR to gain insights into the global influenza vaccination market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/influenza-vaccination-market-1621 

Healthcare Supply Chain Management Market Size, Share, Top Region, Key Players, Application, Status and Forecast 2027

 The need for speedy distribution of healthcare products and services is of critical importance, thus boosting the healthcare supply chain management market. Reports created by MRFR detail the developments in the industry that can be expected in the market through the forecast period. The worldwide market is projected to record an 8.2 % CAGR in the forecast period.

The creation of a strong competitive logistics infrastructure is estimated to guide the advance of the healthcare supply chain management market companies in the future. The availability of funding and customization is estimated to further boost the healthcare supply chain management market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5716 

Segmental Analysis

The segmental evaluation of the healthcare supply chain management market is carried out based on models, function, delivery mode, technology, software, end-users, and region. The models segment of the healthcare supply chain management market has been segmented into continuous replenishment model, make-to-stock model, build-to-order, and chain assembly. The technology segment of the healthcare supply chain management market has been segmented into radio frequency identification (RFID), a barcode, global positioning system (GPS), the internet of things, and big data. The function segment of the healthcare supply chain management market has been segmented into inventory management and procurement, warehousing, and distribution, forecasting and planning, internal logistics and operations, reverse and extended logistics. The region segment of the healthcare supply chain management market has been segmented into Europe, the Middle East, Asia Pacific, the Americas, and Africa. The software segment of the healthcare supply chain management market has been segmented into execution tools and planning tools. The end users’ segment of the healthcare supply chain management market has been segmented into logistics companies and distributors, healthcare providers, and pharmaceutical and biotech companies. The delivery mode segment of the healthcare supply chain management market has been segmented into web-based and on-premise.

Detailed Regional Analysis 

The regional examination of the healthcare supply chain management market has been segmented into Europe, the Middle East, Asia Pacific, the Americas, and Africa. The Americas’ healthcare supply chain management market is anticipated to dominate the global market due to the presence of a large presence of eminent biotech and pharmaceutical companies, an advanced healthcare sector, along with government proposals, and the upsurge in demand for medical devices. The European region is one of the world’s foremost exporter of medicinal and pharmaceutical products and the upsurge in export and import for healthcare-related products will augment the market in this region. The Asia Pacific healthcare supply chain management market due to the increasing incidence of prolonged illness and an upsurge in the call for pharmaceutical products & medical devices is likely to develop quickly.

Competitive Analysis

The market is appraised to be stimulated by an increased development upsurge that is bracing the contenders who are active in the market. The competition in the market is estimated to flare-up following the disruption created by the COVID- pandemic. The emphasis on ensuring sustainability in long-term operations is estimated to be a key cause for development in the upcoming period. The trends in the market are estimated to bolster the progress in the worldwide market. The tendency to invest and expand capacities is estimated to create a promising scope for the market in the impending years. The change in several regulations that are running the development of the market is estimated to impact the innovations that can be seen in the global market. The increased contribution of online channels towards the swell in transactions is predicted to further encourage the advancement of the market in the future. The government intervention in the creation of opportunities that can incentivize the development of key regions in the market is predicted to further add an optimistic touch to the proceedings in the market.

The promising contenders in the healthcare supply chain management market are GHX (US), Infor (US), Oracle (US), Advocate Health Care (Murray, UT), TECSYS (Canada), McKesson (US), SAP (Germany), Manhattan Associates (US), LogiTag Systems (Israel), Jump Technologies (US), JDA Software (US), and others.

Industry Updates:

Mar 2021 SATO, an international auto-ID solutions supplier, introduced the CT4-LX-HC compact desktop printer to tackle healthcare identification needs in the healthcare supply chain. SATO's smart connectivity solution includes feedback from operators on the business's front lines to reduce the stress connected to firmware updates, making settings, and handling label designs for efficient printing of labels to circumvent medical incidents.

Mar 2021 McKesson Corporation, a worldwide healthcare business, revealed a new partnership with Vanderbilt Health Rx Solutions (VHRxS), a nationwide leader in specialty pharmacy strategy and application, to advance VHRxS’s full suite of specialty pharmacy consulting services to McKesson’s health system customers. This new, dedicated offering from VHRxS will balance the experience of McKesson, which has presented industry-leading pharmacy services.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-supply-chain-management-market-5716 

Throat Lozenges Market Foraying into Emerging Economies 2023

 The use of throat lozenges has increased considerably due to the uptick in the occurrence of cold and cough cases globally. Reports created by MRFR detail the developments in the industry that can be expected in the market through the forecast period. The market stands to gain a 4.20% CAGR and produce a market worth of USD 6.58 Billion by the conclusion of 2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1212 

Throat lozenges are being preferred increasingly as they are a convenient option for treating cough, thus spurring the throat lozenge market. The availability of throat lozenges as over-the-counter drugs is estimated to play a vital role in market expansion in the impending period.

Segmental Analysis

The segmental review of the throat lozenge market is carried out on the basis of types, ingredients, indications, and region. The indication segment of thethroat lozenges market consists of cough and cold, sore throat, and throat diseases. The ingredient segment of the throat lozenge market consists of mint, menthol, eucalyptus oil, honey & ginger, lemon, and peppermint oil. The types segment of the throat lozenge market consists of compressed lozenges, soft lozenges, and hard candy lozenges. The regions included in the throat lozenge market are Europe, the Americas, Asia Pacific, and other key regional markets.

Detailed Regional Analysis 

The regional investigation of the throat lozenge market includes regions such as Europe, the Americas, Asia Pacific, and other key regional markets. The regions of North America and South America are generally divided in the Americas, with a segment of over 70 % in the North American regional market’s share. Owing to the appearance of a progressively aging demographic, the Americas regional market for throat lozenges is the chief regional customer segment. Furthermore, the intensifying government expenditure and the incidence of an extensive range of product options are pushing the throat lozenge market. The advance of the European region’s demand for throat lozenges is inspired by the emergence of a substantial number of suppliers of throat lozenges, along with expanding government expenditure and the accessibility to a wide range of product offerings. It is estimated that the Asia Pacific throat lozenge market will be the fastest growing with a 4.77% CAGR through the forecast period. Developing markets such as China, Japan, and India are among the notable markets in the region. The main factors of the APAC throat lozenge market growth are speedy economic expansion, understanding of over-the-counter medicine, and cost-effectiveness.

Competitive Analysis

The trends in the market are estimated to bolster the progress in the worldwide market. The tendency to invest and expand capacities is estimated to create a promising scope for the market in the impending years. The change in several regulations that are running the development of the market is estimated to impact the innovations that can be seen in the global market. The increased contribution of online channels towards the swell in transactions is predicted to further encourage the advancement of the market in the future. The government intervention in the creation of opportunities that can incentivize the development of key regions in the market is predicted to further add an optimistic touch to the proceedings in the market. The market is appraised to be stimulated by an increased development upsurge that is bracing the contenders who are active in the market. The competition in the market is estimated to flare-up following the disruption created by the COVID- pandemic. The emphasis on ensuring sustainability in long-term operations is estimated to be a key cause for development in the upcoming period.

Prestige Brands Inc, Reckitt Benckiser Group plc, Wrigley Company, Gepach International, Procter & Gamble, Bliss GVS Pharma Ltd, Pfizer Inc., Thornton & Ross, Bausch Health Companies Inc, Ricola AG, Ernest Jackson, Mondelēz International group, GlaxoSmithKline, Doestsch Grether AG are some of the primary companies in the throat lozenge market.

Industry Updates:

Feb 2021 The College of Health and Agricultural Sciences of Africa University has made progress in advancing throat lozenges concocted from the zumbani plant, which many Zimbabweans have been sourcing as part of home remedies to combat Covid 19. The novel product, zumbani medicinal cough drops, is projected to help in improving the immune system to fight the disease.

Dec 2020 Applied Biological Laboratories, a New York biotechnology business has introduced Biovanta, the lone drug in the cold, cough, and sore throat category prepared from 100% natural ingredients.  Biovanta is verified as a superior alternative to other important products at checking upper respiratory inflammation as revealed in blind, third-party, placebo-controlled laboratory studies. Biovanta controls cytokines and fortifies the respiratory lining. Important inflammatory molecules examined include bradykinin, which is linked in the cytokine storm-related with COVID-19 and other serious upper respiratory diseases.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/throat-lozenges-market-1212 

Patient Handling Equipment Market Foraying into Emerging Economies 2020-2027

 Global Patient Handling Equipment Market size is expected to be valued at USD 15,430.18 Million by 2027 at a CAGR of 8.3% during the forecast period, 2020-2027.

The advancement in patient handling equipment and expansion of healthcare infrastructure due to the COVID-19 pandemic is expected to boost the growth of the market in the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9986 

An increasing usage of patient handling equipment in hospitals, rehabilitation centers, and elderly care settings is expected to drive the growth of the global patient handling equipment market.

The market growth in the coming years can also be attributed to the business expansion of manufacturers through merger & acquisition and incessant launch of innovative products. For instance, in the year 2020, Invacare Corporation, a US-based long-term medical product manufacturer, announced the launch of an Invacare AVIVA FX Power Wheelchair, a front-wheel-drive wheelchair. This product launch was aimed to strengthen the company’s power mobility product portfolio.

Market USP

Growing patient population of chronic diseases and rising geriatric population are the major market influencer of the patient handling equipment market.  

Market Drivers

The rising influx of patients in the hospital due to an outbreak of COVID-19 pandemic. The critical care products including hospital beds, ventilators, and vitals monitoring devices are being used in abundance for patients suffering from COVID-19. Various companies are aiding the healthcare sector in meeting the rising demand for critical care products by increasing their manufacturing capacity. For instance, in May 2020, Stryker (US) delivered about 1,000 emergency relief beds to hospitals in Qatar. The company is also massively producing emergency relief beds, a low-cost hospital bed.      

• Increasing geriatric and obese population

• Risk of injuries to caregivers while manual handling of patients

• Implementation of regulations to ensure the safety of healthcare service providers during the manual lifting procedure. For instance, according to the Office of State Human Resources (OSHR), the caregiver should do a preliminary assessment of their safety & health risks before any manual handling operation and take appropriate steps to lower the risks of patient handling. Also, manual handling operations should be avoided as far as it is reasonably practicable.

• A growing number of road accidents

• Growing usage of ceiling lifts in hospitals

Market Restraints

• Low skilled professionals for the efficient operation of the patient handling equipment.

Segmentation

By Product

• Patient Transfer Devices: This segment is likely to hold the largest share owing to the growing number of obese patients. This segment is further fragmented into patient lifts, air-assisted lateral transfer mattresses, sliding sheets, and accessories. Patient transfer devices aid in long and short distance transfer of patients depending on the requirement. Also, these products provide caregivers reduced risk of injuries while patient handling and are time efficient. According to National Public Radio, every year about 35,000 nursing professionals experience back and body injuries during patient handling in the US region.

• Medical Beds: This segment is further segmented into manual beds, electric beds, and semi-electric beds. The rising number of COVID-19 patients has influx the demand for medical beds in the forecast period. Also, the growing geriatric population base susceptive to chronic disease will be driving the growth of the segment. For instance, in 2019, according to the United Nations, globally there were about 703 million people aged 65 or over.

• Mobility Devices: This segment is further segmented into wheelchairs & mobility scooters, and ambulatory aids. The increasing cases of disability are expected to propel the demand for mobility devices. The ambulatory aid equipment provides support, stability, and balance for patients. The ambulatory aid segment includes equipment such as crutch, cane walking, walker, and others.

• Bathroom & Toilet Assist Equipment: These segments include bathroom assist products such as commodes, bath aids, handgrips, bath lifts, shower chairs, and others. Easy availability in online stores is likely to propel the growth of the segment.

• Stretchers & Transport Chairs: These are used in carrying patients from one place to another, within and outside of a healthcare facility. The advancement in stretchers & transport chairs has been enabling clinicians in providing patients with proper emergency assistance.

By Application

• Acute & Critical Care: This segment is likely to hold the largest share owing to high prevalence rate cardiovascular diseases, viral infection, and other acute diseases. For instance, in 2017, according to the Centers for Disease Control and Prevention (CDC), about 18.2 million adult population aged 20 or older were suffering from coronary heart disease in the US region.

• Long Term Care: This segment is likely to be the fastest-growing segment owing to the growing prevalence of target diseases such as tuberculosis, Alzheimer’s disease, tetanus, and others. For instance, according to Alzheimer's Association, in the US, about 5.8 million people aged 65 or above were suffering from Alzheimer’s dementia in 2019 and 5.7 million in 2018.

• Mobility Assistance: The growth of this segment can be attributed to the growing incidence rate of diseases such as arthritis and Parkinson’s.  For instance, according to Parkinson's Foundation, every year about 60,000 of the American population are diagnosed with Parkinson’s disease. This disease is characterized by stiffness, slowed movement, tremors, and impaired balance. The mobility assistance devices improve balance and provide support to patients suffering from Parkinson’s disease. Also, the rising elderly population is expected to drive the growth of the segment.

By End-User

• Hospitals: Hospitals segment dominated the market share owing to increasing healthcare infrastructure and rising investment. According to MRFR analysis, the investments made in hospital and healthcare services for the year 2017 and 2018 in some European countries are the following:

By Region

• Americas: The largest regional market. The increasing prevalence rate of obesity is expected to boost the growth of the market during the forecast period. For instance, in the US, according to the Centers for Disease Control and Prevention (CDC), in 2017-18, the prevalence of obesity was around 42.2%, which was about 39.8% in 2015-16.

• Europe: Europe held the second-largest position in the patient handling equipment market owing to high research and development investment. For instance, in 2017, according to MedTech Europe, about 40% of total patent applications in medical technology were filed from European countries.

• Asia-Pacific: The fastest-growing regional market for patient handling equipment owing to the growing life expectancy rate. According to the World Bank, the life expectancy at birth in the South Asia region in 2017 and 2018 were 69.1 year and 69.4 years, respectively. Also, growing healthcare expenditure is driving the growth of the market. For instance, in 2017, according to the World Bank, the healthcare expenditure of Japan, China and India was about 10.94%, 5.15%, and 3.53%, respectively. Such increasing expenditure backed by life expectancy rate is expected to boost the demand for patient handling devices in the coming years

• Middle East & Africa: This region is expected to show steady growth owing to the high rate of obesity. For instance, in 2016, according to the World Health Organization, about 28.3% of adults and 81.3% of women are suffering from obesity in the South African region. However, low healthcare infrastructure in the region is expected to hinder the market growth in the forecast period.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/patient-handling-equipment-market-9986 

Global Nebulizers Market 2020 Industry Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast By 2027

 Nebulizers are a device that has the capability of changing a medication from a liquid to a mist so that it can be inhaled into the lungs. High demand for respiratory devices, including nebulizers, due to the outbreak of COVID-19 globally, growing need for rescue medication, increasing prevalence of respiratory diseases, and rising demand for home healthcare devices are the key factors that are expected to drive the market growth. Moreover, the growing geriatric population, increasing consumption of alcohol, tobacco, cigarettes, and other such products may lead to respiratory diseases, and the rising number of initiatives taken by the government as well as the private organizations are also expected to boost the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9586 

According to MRFR analysis, the Global Nebulizers Market size is expected to register a CAGR of 7.32% during the forecast period of 2020 to 2027 and reach USD 1,629.7 Million by 2027.

A nebulizer is a type of breathing machine that is used to take inhaled medicines. Nebulizer treatment is carried out with an air compressor machine.

The growth of the global nebulizers market can be contributed to the growing need for rescue medication, high demand for respiratory devices, including nebulizers, due to outbreak of COVID-19 globally, and increasing prevalence of chronic respiratory diseases. According to a press release from Icon Plc in April 2020, the demand for respiratory devices has enormously increased, due to the rising cases of COVID-19.

Furthermore, the growing demand for home healthcare devices, rising geriatric population, increasing consumption of alcohol, tobacco, cigarettes, and other such products that might lead to respiratory diseases, are also expected to fuel the market growth during the forecast period.

However, the loss of drug during nebulization procedures, availability of various substitutes for nebulizers, and side effects of nebulizer solutions are expected to restrain the growth of the global nebulizers market.

Several market players such as OMRON Healthcare, Koninklijke Philips N.V., and B. Braun Melsungen AG, among others currently dominate the global nebulizers market. The key players are involved in awareness campaigns, product approvals, mergers, and strategic collaborations to strengthen their market positions. For instance, in April 2020, B. Braun Melsungen AG received the Food and Drugs Administration (FDA) emergency use authorization for using its infusion pumps with nebulizers to treat COVID-19 patients.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the rising demand for respiratory diseases in the region. The nebulizers market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European nebulizers market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The nebulizers market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing incidence rate of respiratory diseases, the market in Asia-Pacific is expected to be the fastest-growing. The nebulizers market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global Nebulizers Market has been Segmented Based on the Type, Usage, Portability, and End User.

Based on the Type, the global nebulizers market has been segmented into mesh, jet, and ultrasonic. The mesh segment is further divided into active and passive. The jet segment is expected to hold the largest market share owing to its low cost as compared to other types of nebulizers.

On the basis of usage, the market has been segmented into reusable and disposable. The disposable nebulizers are expected to hold a major market share owing to their growing popularity amongst the users.

Based on the portability, the market has been segmented into tabletop and portable. The portable nebulizers market is expected to grow at the fastest CAGR owing to its ease and convenience of use.

The market based on end-user has been segmented into hospitals & clinics, home care, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals.

Key Players

Some of the key players in the global nebulizers market are OMRON Healthcare (Japan), Koninklijke Philips N.V. (Netherlands), PARI (US), Vectura Group plc (UK), Rossmax International Ltd (Taiwan), Briggs Healthcare (US), GF Health Products, Inc. (US), Beurer GmBH (Germany), Agilent Technologies, Inc. (US), Drive DeVilbiss Healthcare (US), Invacare Corporation (US), and B. Braun Melsungen AG (Germany).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/nebulizers-market-9586